Recent studies demonstrate that growth inhibition after VP treatment is independent of YAP1 expression or that of the related Hippo effector TAZ in colon cancer [25], which is in line with our finding that YAP1 expression did not correlate with sensitivity to VP in GC cell lines. The gene discussed is YAP1; the disease is malignant colon neoplasm.